Skip to main content
Clinical Trials/ISRCTN55473884
ISRCTN55473884
Completed
未知

Impact of a multifaceted, targeted intervention on the human papillomavirus vaccination rate in Swiss Primary Care: a cluster randomized controlled trial

MSD (Switzerland)0 sites1,980 target enrollmentJune 4, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Human papillomavirus
Sponsor
MSD (Switzerland)
Enrollment
1980
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 4, 2021
End Date
December 31, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
MSD (Switzerland)

Eligibility Criteria

Inclusion Criteria

  • The study patient population is equal to the target population of the vaccines of interest. GPs will provide vaccinations according to the current Swiss vaccination recommendations publicized by the Swiss Ministry of Health (Swiss vaccination schedule 2020\)

Exclusion Criteria

  • Does not meet inclusion criteria

Outcomes

Primary Outcomes

Not specified

Similar Trials